期刊： BREAST CANCER-TARGETS AND THERAPY, 2021; 13 ()
Eribulin mesylate, a synthetic derivative of the anti-mitotic agent halichondrin B, has a unique tubulin-based mechanism of action that is distinct fr......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2020; 12 ()
Purpose: The compound traditional Chinese medicine Xihuang pill (XHP) has been adopted to treat breast cancer (BC) for centuries, but its specific mec......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Background: The role of the 8th American Joint Committee on Cancer (AJCC) pathological prognostic staging (PPS) on treatmentdecision making of breast ......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Background: Histological grade is an important factor in the overall prognosis of patients with invasive breast cancer. Therefore, the non-invasive as......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Background: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer. Metformin has been shown to have the potential to inhibit ......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is mainly treated with chemotherapy-based combination therapy......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Objective: We have found that miR-381 can regulate the proliferation of breast cancer cells by regulating TWIST protein, it can serve as a potential m......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Aim: This study investigated the role and mechanism of insulin-like growth factor 2-IGF2BP2 in breast cancer.Methods: IGF2BP2 is overexpressed in MDA-......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Introduction: Tripartite motif-containing protein (TRIM) family members play crucial roles in carcinogenesis and chemotherapy resistance. In this stud......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Purpose: Multiple reports have demonstrated that highly expressed chloride intracellular channel 1 (CLIC1) exists in a range of malignant tumors and i......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Background: Breast cancer stem cells (BCSCs) are associated with tumor initiation, invasion, metastasis and drug resistance. It is known that many pro......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Objective: Because tumor tissues are most frequently heterogeneous and hard to characterize, the resulting therapeutic strategy could be misled. The m......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Purpose: To explore the efficacy, safety, and potential factors influencing efficacy and outcome of pyrotinib-based therapy in human epidermal growth ......
期刊： BREAST CANCER-TARGETS AND THERAPY, 2022; 14 ()
Purpose: Recently, the DESTINY-Breast04 trial revealed that significant benefits in both overall survival (OS) and progression-free survival (PFS) in ......
